Becker's Healthcare July 19, 2024
Andrew Cass

Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice are mulling a rival bid to take over R1 RCM, Bloomberg reported July 18.

Any bid would compete against a $13.25-per-share proposal made by R1’s largest investor, New Mountain Capital, according to the report.

New Mountain and TCP-ASC — an investment vehicle jointly owned by TowerBrook and Ascension Health Alliance — previously discussed a joint proposal to take R1 private but were unable...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Mergers & Acquisitions / JV, RCM (Revenue Cycle Mgmt), Technology, Trends
Related Articles:
Aspirion lands 7th acquisition in 6 years
Revenue Cycle Risk Takers
Revenue Cycle AI Is Costly and Cumbersome. Here's Why Leaders Are Still Buying In.
Medical Tourism and Global Private Healthcare Drive Revenue Cycle Innovation: Black Book Report
4 Cornerstones for Successful AI Implementation in Hospital Revenue Cycle Management in 2025

Share This Article